elpais.com/sociedad/202...
elpais.com/sociedad/202...
elpais.com/sociedad/202...
elpais.com/sociedad/202...
elpais.com/clima-y-medi...
elpais.com/clima-y-medi...
elpais.com/sociedad/202...
elpais.com/sociedad/202...
elpais.com/sociedad/202...
elpais.com/sociedad/202...
elpais.com/sociedad/202...
elpais.com/sociedad/202...
elpais.com/sociedad/202...
elpais.com/sociedad/202...
elpais.com/sociedad/202...
elpais.com/sociedad/202...
elpais.com/sociedad/202...
elpais.com/sociedad/202...
elpais.com/sociedad/202...
elpais.com/sociedad/202...
elpais.com/sociedad/202...
elpais.com/sociedad/202...
elpais.com/sociedad/202...
elpais.com/sociedad/202...
elpais.com/sociedad/202...
elpais.com/sociedad/202...
2.5 days full of patient stories, AI, policy discussions, trial designs & networking to make #DrugRepurposing the new normal💊🌍
👏Big thanks to all teams & speakers!
📰Great recap by @oriolguell.bsky.social
EN: loom.ly/qzQoFDY
#RareDiseases #PatientCentredResearch
🌍 300+ joined us in Amsterdam for two days of panels, posters, and powerful discussions on smarter routes to repurposed medicines.
👥 Thanks to our speakers and attendees for your insights, energy & contributions.
📖Highlights: remedi4all.org/idr25-wraps-...
2.5 days full of patient stories, AI, policy discussions, trial designs & networking to make #DrugRepurposing the new normal💊🌍
👏Big thanks to all teams & speakers!
📰Great recap by @oriolguell.bsky.social
EN: loom.ly/qzQoFDY
#RareDiseases #PatientCentredResearch
elpais.com/sociedad/202...
elpais.com/sociedad/202...
elpais.com/espana/catal...
elpais.com/espana/catal...